169 related articles for article (PubMed ID: 12689942)
1. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study.
Tracey L; Villuendas R; Dotor AM; Spiteri I; Ortiz P; Garcia JF; Peralto JL; Lawler M; Piris MA
Blood; 2003 Aug; 102(3):1042-50. PubMed ID: 12689942
[TBL] [Abstract][Full Text] [Related]
2. miRNA expression profiling of mycosis fungoides.
van Kester MS; Ballabio E; Benner MF; Chen XH; Saunders NJ; van der Fits L; van Doorn R; Vermeer MH; Willemze R; Tensen CP; Lawrie CH
Mol Oncol; 2011 Jun; 5(3):273-80. PubMed ID: 21406335
[TBL] [Abstract][Full Text] [Related]
3. Combined use of PCR-based TCRG and TCRB clonality tests on paraffin-embedded skin tissue in the differential diagnosis of mycosis fungoides and inflammatory dermatoses.
Zhang B; Beck AH; Taube JM; Kohler S; Seo K; Zwerner J; Viakhereva N; Sundram U; Kim YH; Schrijver I; Arber DA; Zehnder JL
J Mol Diagn; 2010 May; 12(3):320-7. PubMed ID: 20203005
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
5. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
[TBL] [Abstract][Full Text] [Related]
6. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
[TBL] [Abstract][Full Text] [Related]
7. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.
van Kester MS; Borg MK; Zoutman WH; Out-Luiting JJ; Jansen PM; Dreef EJ; Vermeer MH; van Doorn R; Willemze R; Tensen CP
J Invest Dermatol; 2012 Aug; 132(8):2050-9. PubMed ID: 22513784
[TBL] [Abstract][Full Text] [Related]
9. [Current possibilities of the differential diagnosis of plaque parapsoriasis and the early stages of mycosis fungoides].
Olisova OY; Grekova EV; Varshavsky VA; Gorenkova LG; Alekseeva EA; Zaletaev DV; Sydikov AA
Arkh Patol; 2019; 81(1):9-17. PubMed ID: 30830099
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.
Bastidas Torres AN; Cats D; Mei H; Szuhai K; Willemze R; Vermeer MH; Tensen CP
Genes Chromosomes Cancer; 2018 Dec; 57(12):653-664. PubMed ID: 30144205
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Gene Expression in Cutaneous T-Cell Lymphoma: Systematic Review of Transcriptomic Studies in Mycosis Fungoides.
Motamedi M; Xiao MZX; Iyer A; Gniadecki R
Cells; 2021 Jun; 10(6):. PubMed ID: 34204115
[TBL] [Abstract][Full Text] [Related]
12. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
Yuki A; Shinkuma S; Hayashi R; Fujikawa H; Kato T; Homma E; Hamade Y; Onodera O; Matsuoka M; Shimizu H; Iwata H; Abe R
J Am Acad Dermatol; 2018 Dec; 79(6):1039-1046. PubMed ID: 29928911
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis.
Lai J; Li J; Gniadecki R; Lai R
Cells; 2021 Nov; 10(11):. PubMed ID: 34831413
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
15. Early-stage mycosis fungoides variants: case-based review.
Cho-Vega JH; Tschen JA; Duvic M; Vega F
Ann Diagn Pathol; 2010 Oct; 14(5):369-85. PubMed ID: 20850703
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides: A great imitator.
Hodak E; Amitay-Laish I
Clin Dermatol; 2019; 37(3):255-267. PubMed ID: 31178107
[TBL] [Abstract][Full Text] [Related]
18. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of Fas in tumour-stage mycosis fungoides (MF) and MF-like cutaneous T-cell pseudolymphoma.
Debusscher C; Simonart T
Br J Dermatol; 2001 Apr; 144(4):903. PubMed ID: 11298560
[No Abstract] [Full Text] [Related]
20. A simple clinical scoring system to improve the sensitivity and standardization of the diagnosis of mycosis fungoides type cutaneous T-cell lymphoma: logistic regression of clinical and laboratory data.
Stevens SR; Ke MS; Birol A; Terhune MH; Parry EJ; Ross C; Mostow EN; Gilliam AC; Cooper KD;
Br J Dermatol; 2003 Sep; 149(3):513-22. PubMed ID: 14510983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
